About job:

PhD student in chemokine immunobiology - HORIZON-MSCA-2022-DN Doctoral Network “B-ACTIVE”These projects, funded by the Marie Skłodowska-Curie Actions (MSCA)-doctoral network program  "B-ACTIVE", is a EU-funded collaboration between the universities of Leuven, Copenhagen, Graz, Ljubljana, Uppsala and several industrial partners located in Copenhagen, Uppsala, Graz, Cambridge and Paris (see https://b-active-dn.

eu). In the B-ACTIVE consortium, fundamental and clinical scientists and companies will study the impact of posttranslational modifications of chemokine ligands and receptors while training 10 doctoral candidates into future experts with translational and interdisciplinary mindsets.

The doctoral candidates will characterize interactions between chemokine ligands, receptors and glycosaminoglycans, study signaling pathways and recognize their importance in inflammatory reactions. B-ACTIVE thus provides training in the complexity of inflammatory responses from basic science to clinical applications and industrial development.

B-ACTIVE aims to unite fundamental and clinical scientists with pharmaceutical companies to explore the impact of posttranslational modifications of chemokine ligands and receptors. The project’s goal is to enhance our comprehension of inflammatory responses, pinpoint the right drug targets, and actively contribute to pharmaceutical development, ultimately improving patient treatment.

The MSCA doctoral networks aim to train creative, entrepreneurial, innovative and resilient doctoral candidates, able to face current and future challenges and to convert knowledge into societal benefit.

Profile We are seeking a highly motivated PhD candidate to contribute to this project at Uppsala University under supervision of Prof. Mia Phillipson. Applicants should have a master degree in Biomedical Sciences, Biochemistry, Pharmacy, Biotechnology, Immunology, Microbiology, or closely related fields, and a genuine interest in immunology and physiology.

We require candidates to be self-driven, ambitious,  well-organized and enthusiastic about science and to work well in teams. Emphasis will be placed on previous work in laboratory environment and research experience.

Experience with proteomics and metagenomics is considered meritorious for applicants when filling the position. Successful candidate will be part of an international network with industrial and scientific partners across Europe via the MSCA/Doctoral Network 'B-ACTIVE'.

Regular meetings, workshops and international secondments within the B-ACTIVE network will supplement the training and support provided at the host laboratory.Requirements Rules governing PhD students are set out in the Higher Education Ordinance chapter 5, §§ 1-7, in Uppsala University's rules and guidelines and by the HORIZON-MSCA-2022-DN Doctoral Network (https://marie-sklodowska-curie-actions.

ec.europa.eu/actions/how-to-apply#PhD).We welcome applications from Doctoral Researcher candidates fulfilling the following criteria:Researchers must be doctoral candidates, i.e. not having already received a PhD or equivalent degree by any institution; researchers who have successfully defended their doctoral thesis but who have not yet formally been awarded the doctoral degree will not be considered eligible.

Applicants can be of any nationality but must not have resided or carried out their main activity (work, studies, etc.) in Sweden for more than 12 months in the 36 months immediately before their recruitment date.

Time spent as part of a procedure for obtaining refugee status under the Geneva Convention (1951 Refugee Convention and the 1967 Protocol), compulsory national service, and/or short stays such as holidays are not considered.

Applicants preferably have not more than 3 years post-master seniority. Applicants must be eligible to work as PhD student in Sweden according to national and European regulations (e.g. visa requirements), and also to travel/work in other European countries for collaborations/secondments and trainings.

Applicants should be proficient in written and spoken English and agreeing to use such language both for work and for any other official matter, including the selection process. Applicants must be available to enroll full-time by November 2024, but an earlier start date is possible.

Applicants are aware of and adhere to the principles set out in the Commission Recommendation on the European Charter for Researchers (https://euraxess.ec.europa.eu/jobs/charter/european-charter). Applicants agree to undertake the PhD training program associated to this position (https://www.

uu.se/en/staff/disciplinary-domain/medicine-and-pharmacy/education-and-teaching/doctoral-studies), in case they are selected.Observera att detta är en förkortad version av annonsen. För att se den fullständiga annonsen vänligen klicka på ”Ansök här” eller se Uppsala universitets hemsida: https://uu.

se/jobb/About the employment The employment is a temporary position according to the Higher Education Ordinance chapter 5 § 7. Scope of employment 100 %. Starting date as agreed. Placement: UppsalaFor further information about the position, please contact: Mia Phillipson, mia.

[email protected] submit your application by 31 May 2024, UFV-PA 2024/1062.Are you considering moving to Sweden to work at Uppsala University? Find out more about what it´s like to work and live in Sweden.

Uppsala universitet är ett brett forskningsuniversitet med stark internationell ställning. Det yttersta målet är att bedriva utbildning och forskning av högsta kvalitet och relevans för att göra skillnad i samhället.

Vår viktigaste tillgång är alla 7 600 anställda och 53 000 studenter som med nyfikenhet och engagemang gör Uppsala universitet till en av landets mest spännande arbetsplatser.Läs mer om våra förmåner och hur det är att jobba inom Uppsala universitet https://uu.

se/om-uu/jobba-hos-oss/Vi undanber oss erbjudanden om rekryterings- och annonseringshjälp.Ansökan tas emot i Uppsala universitets rekryteringssystem.